Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice

被引：214

作者：

Dosenovic, Pia ^{[1
]}

von Boehmer, Lotta ^{[1
]}

Escolano, Amelia ^{[1
]}

Jardine, Joseph ^{[3
,10
,11
]}

Freund, Natalia T. ^{[1
]}

Gitlin, Alexander D. ^{[1
]}

McGuire, Andrew T. ^{[4
]}

Kulp, Daniel W. ^{[3
,10
,11
]}

Oliveira, Thiago ^{[1
]}

Scharf, Louise ^{[5
]}

Pietzsch, John ^{[1
]}

Gray, Matthew D. ^{[4
]}

Cupo, Albert ^{[6
]}

van Gils, Marit J. ^{[7
]}

Yao, Kai-Hui ^{[1
]}

Liu, Cassie ^{[1
]}

Gazumyan, Anna ^{[1
,2
]}

Seaman, Michael S. ^{[8
]}

Bjoerkman, Pamela J. ^{[2
,5
]}

Sanders, Rogier W. ^{[6
]}

Moore, John P. ^{[6
]}

Stamatatos, Leonidas ^{[4
,9
]}

Schief, William R. ^{[3
,10
,11
,12
]}

Nussenzweig, Michel C. ^{[1
,2
]}

机构：

[1] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA

[2] Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA

[3] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA

[4] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA

[5] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA

[6] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA

[7] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands

[8] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA

[9] Univ Washington, Dept Global Hlth, Seattle, WA 98109 USA

[10] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA

[11] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA

[12] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA

来源：

CELL | 2015年 / 161卷 / 07期

基金：

欧洲研究理事会; 加拿大健康研究院; 瑞典研究理事会;

关键词：

B-CELL RECEPTORS; ENVELOPE TRIMER; SOMATIC HYPERMUTATION; VACCINE; VIRUS; GP120; SITE; RECOMBINATION; GLYCOPROTEIN; AFFINITY;

D O I：

10.1016/j.cell.2015.06.003

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A subset of individuals infected with HIV-1 develops broadly neutralizing antibodies (bNAbs) that can prevent infection, but it has not yet been possible to elicit these antibodies by immunization. To systematically explore how immunization might be tailored to produce them, we generated mice expressing the predicted germline or mature heavy chains of a potent bNAb to the CD4 binding site (CD4bs) on the HIV-1 envelope glycoprotein (Env). Immunogens specifically designed to activate B cells bearing germline antibodies are required to initiate immune responses, but they do not elicit bNAbs. In contrast, native-like Env trimers fail to activate B cells expressing germline antibodies but elicit bNAbs by selecting for a restricted group of light chains bearing specific somatic mutations that enhance neutralizing activity. The data suggest that vaccination to elicit anti-HIV-1 antibodies will require immunization with a succession of related immunogens.

引用

页码：1505 / 1515

页数：11

共 50 条

[41] Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
Parks, K. Rachael
MacCamy, Anna J.
Trichka, Josephine
Gray, Matthew
Weidle, Connor
Borst, Andrew J.
Khechaduri, Arineh
Takushi, Brittany
Agrawal, Parul
Guenaga, Javier
Wyatt, Richard T.
Coler, Rhea
Seaman, Michael
LaBranche, Celia
Montefiori, David C.
Veesler, David
Pancera, Marie
McGuire, Andrew
Stamatatos, Leonidas
CELL REPORTS, 2019, 29 (10): : 3060 - +
[42] Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection
Derdeyn, Cynthia A.
Moore, Penny L.
Morris, Lynn
CURRENT OPINION IN HIV AND AIDS, 2014, 9 (03) : 210 - 216
[43] Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody
Dingens, Adam S.
Haddox, Hugh K.
Overbaugh, Julie
Bloom, Jesse D.
CELL HOST & MICROBE, 2017, 21 (06) : 777 - +
[44] Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor
Spencer, David A.
Malherbe, Delphine C.
Bernat, Nestor Vazquez
Adori, Monika
Goldberg, Benjamin
Dambrauskas, Nicholas
Henderson, Heidi
Pandey, Shilpi
Cheever, Tracy
Barnette, Philip
Sutton, William F.
Ackerman, Margaret E.
Kobie, James J.
Sather, D. Noah
Hedestam, Gunilla B. Karlsson
Haigwood, Nancy L.
Hessell, Ann J.
JOURNAL OF IMMUNOLOGY, 2021, 206 (05) : 999 - 1012
[45] Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies
Kim, Jiae
Jobe, Ousman
Peachman, Kristina K.
Michael, Nelson L.
Robb, Merlin L.
Rao, Mangala
Rao, Venigalla B.
VIROLOGY, 2017, 508 : 188 - 198
[46] Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers
Sliepen, Kwinten
Medina-Ramirez, Max
Yasmeen, Anila
Moore, John P.
Klasse, Per Johan
Sanders, Rogier W.
VIROLOGY, 2015, 486 : 116 - 120
[47] V4 region of the HIV-1 envelope gene mediates immune escape and may not promote the development of broadly neutralizing antibodies
Ji, Yangtao
Han, Xiaoxu
Tian, Wen
Gao, Yang
Jin, Su
Zhang, Linqi
Shang, Hong
VACCINE, 2018, 36 (50) : 7700 - 7707
[48] Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies
Xiao, Xiaodong
Chen, Weizao
Feng, Yang
Dimitrov, Dimiter S.
VIRUSES-BASEL, 2009, 1 (03): : 802 - 817
[49] Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent
Noailly, Blandine
Yaugel-Novoa, Melyssa
Werquin, Justine
Jospin, Fabienne
Drocourt, Daniel
Bourlet, Thomas
Rochereau, Nicolas
Paul, Stephane
VACCINES, 2022, 10 (06)
[50] Centralized HIV-1 envelope immunogens and neutralizing antibodies
Gao, Feng
Liao, Hua-Xin
Hahn, Beatrice H.
Letvin, Norman L.
Korber, Bette T.
Haynes, Barton F.
CURRENT HIV RESEARCH, 2007, 5 (06) : 572 - 577

← 1 2 3 4 5 →